During the past decade, Tyler Eye Associates conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 17 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 17 clinical trials were completed. i.e. 89.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyler Eye Associates" #1 collaborator was "Visioncare Research Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tyler Eye Associates" are "Visual Acuity" (19 trials), "Myopia" (2 trials), "Hyperopia" (1 trials) and "Ocular Physiology" (1 trials). Many other conditions were trialed in "Tyler Eye Associates" in a lesser frequency.

Most popular intervention types in "Tyler Eye Associates" are "Device" (22 trials). Other intervention types were less common.

The name of intervention was led by "senofilcon A C3" (3 trials), "ACUVUE Oasys 1-Day" (2 trials), "Dailies Total 1® Multifocal Contact Lenses" (2 trials), "senofilcon A" (2 trials) and "ACUVUE OASYS 1-Day for Astigmatism" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tyler Eye Associates" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tyler Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Tyler Eye Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tyler Eye Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 22 trials that are defined as “Not Applicable".